Facultad
Instituto de Investigación, Innovación y Tecnología Educativas (UNIR iTED)
Argitalpenak (49) Ikertzaileren baten partaidetza izan duten argitalpenak
2015
-
A Quantitative Justification to Dynamic Partial Replication of Web Contents through an Agent Architecture
IJIMAI, Vol. 3, Núm. 3, pp. 82-88
-
A design process for balanced educational video games with collaborative activities
DYNA: revista de la Facultad de Minas. Universidad Nacional de Colombia. Sede Medellín, Vol. 82, Núm. 193, pp. 223-232
-
A visual analytics method for score estimation in learning courses
Journal of Universal Computer Science, Vol. 21, Núm. 1, pp. 134-155
-
A4Learning: An iterative methodological approach to support better learning and teaching
IEEE Latin America Transactions, Vol. 13, Núm. 2, pp. 483-489
-
Advances in treating drug-resistant hepatitis B virus in HIV-infected patients
Expert Opinion on Pharmacotherapy, Vol. 16, Núm. 2, pp. 179-186
-
An explanatory framework for understanding teachers resistance to adopting educational technology
Kybernetes, Vol. 44, Núm. 8-9, pp. 1240-1250
-
An intelligent Mobile Web Browser to adapt the mobile web as a function of the physical environment
IEEE Latin America Transactions, Vol. 13, Núm. 2, pp. 503-509
-
Analysis and improvement of the management of IT projects
IEEE Latin America Transactions, Vol. 13, Núm. 7, pp. 2366-2371
-
Assessment of learning in environments interactive through fuzzy cognitive maps
Soft Computing, Vol. 19, Núm. 4, pp. 1037-1050
-
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study
HIV Medicine, Vol. 16, Núm. 9, pp. 533-543
-
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study
PLoS ONE, Vol. 10, Núm. 10
-
Comparing and modelling land use organization in cities
Royal Society Open Science, Vol. 2, Núm. 12
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
-
Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe
Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1027-1032
-
Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs
Virology Journal, Vol. 12, Núm. 1
-
Dolutegravir for the treatment of HIV-2 infection
Journal of Clinical Virology, Vol. 64, pp. 12-15
-
Drug interactions with new hepatitis C oral drugs
Expert Opinion on Drug Metabolism and Toxicology, Vol. 11, Núm. 3, pp. 333-341
-
Dual antiviral therapy for HIV and hepatitis C - Drug interactions and side effects
Expert Opinion on Drug Safety, Vol. 14, Núm. 9, pp. 1421-1434
-
Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis
Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 2, pp. 1282-1291
-
Emerging Challenges in Managing Hepatitis B in HIV Patients
Current HIV/AIDS Reports, Vol. 12, Núm. 3, pp. 344-352